UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053140
Receipt number R000060646
Scientific Title Investigation of Atrial Fibrillation Incidence in Hypertensive Patients
Date of disclosure of the study information 2023/12/18
Last modified on 2023/12/18 12:16:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Incidence of Atrial Fibrillation in Hypertensive Patients and Development of Risk Factor Management Methods to Prevent the Atrial Fibrillation

Acronym

Investigation of Atrial Fibrillation Incidence in Hypertensive Patients

Scientific Title

Investigation of Atrial Fibrillation Incidence in Hypertensive Patients

Scientific Title:Acronym

Investigation of Atrial Fibrillation Incidence in Hypertensive Patients

Region

Japan


Condition

Condition

hypertension

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to understand the incidence of new onset of atrial fibrillation in hypertensive patients and to develop a risk factor management method utilizing PHR.

Basic objectives2

Others

Basic objectives -Others

Identification of risk factors and development of an AI model for the prevention of atrial fibrillation and its management

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Detection rate of new atrial fibrillation in hypertensive patients over 60 years of age by continuous electrocardiographic recordings over a 3-month period.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with a history of hypertension and taking antihypertensive medication
(2) Patients 60 years of age or older
(3) Patients with consent

Key exclusion criteria

(1) Patients currently participating or planning to participate in an interventional trial
(2) Patients with a confirmed diagnosis of atrial fibrillation (self-reported)
(3) Patients on anticoagulants (self-reported)
(4) Patients with an implanted pacemaker or defibrillator
(5) Patients residing outside Japan
(6) Patients who are judged to be inappropriate to participate in the study by the physician in charge

Target sample size

4000


Research contact person

Name of lead principal investigator

1st name Keitaro
Middle name
Last name Senoo

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Cardiac Arrhythmia Research and Innovation

Zip code

602-8566

Address

465 Kajiichou, Hirokouji, Kawaramachi, Kamigyo-ku, Kyoto

TEL

08031117168

Email

k-senoo@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Keitaro
Middle name
Last name Senoo

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Cardiac Arrhythmia Research and Innovation

Zip code

602-8566

Address

465 Kajiichou, Hirokouji, Kawaramachi, Kamigyo-ku, Kyoto

TEL

0752515511

Homepage URL


Email

k-senoo@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Omron healthcare company

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB center Kyoto Prefectural University of Medicine

Address

465 Kajiichou, Hirokouji, Kawaramachi, Kamigyo-ku, Kyoto

Tel

0752515337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 03 Month 31 Day

Date of IRB

2021 Year 03 Month 31 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2023 Year 07 Month 31 Day

Date of closure to data entry

2023 Year 10 Month 31 Day

Date trial data considered complete

2023 Year 11 Month 30 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

Analysis is currently underway.


Management information

Registered date

2023 Year 12 Month 18 Day

Last modified on

2023 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060646


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name